NCT02221830

Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: University of Colorado, Denver · Academic / Other
• Sex: Female
• Age: 13 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

Evaluation of the efficacy of postpartum 24 hour oxytocin infusion to reduce blood loss in patients with pre-eclampsia (PE)

Detailed description

The overall goal of this study is to evaluate the efficacy of postpartum 24 hour oxytocin infusion as a prevention-oriented strategy to reduce blood loss in patients with pre-eclampsia (PE) in a blinded, placebo controlled, randomized controlled trial.

Conditions

• Preeclampsia

Interventions

Type	Name	Description
DRUG	Oxytocin	Our intervention simply replaces the standardly given normal saline with treatment (normal saline + oxytocin)
DRUG	Placebo	This intervention utilizes a Placebo Camparator

Timeline

• Start date: 2015-02-01
• Primary completion: 2019-07-17
• Completion: 2019-07-17
• First posted: 2014-08-20
• Last updated: 2021-05-07

Locations

1 site across 1 country: United States